A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Clinical trial NCT06008379 · UNKNOWN

Trial details

NCT number: NCT06008379
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-08-28
Primary completion: 2025-08-30
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.